116 related articles for article (PubMed ID: 25687075)
1. [Genotype analysis and telomere length measure in patients with dyskeratosis congenita].
Zhang JY; An WB; Zhang L; Chang LX; Qi BQ; Liu TF; Liu F; Yang WY; Guo Y; Zhu XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):212-6. PubMed ID: 25687075
[TBL] [Abstract][Full Text] [Related]
2. [Dyskeratosis congenital: clinical features and genotype analysis in two Chinese patients].
Liu R; Shi XD; Wang TY; Liu ZQ; Hu T; Fan W; Cao J; Hou R; Liang C; Huang SA
Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):684-7. PubMed ID: 22339828
[TBL] [Abstract][Full Text] [Related]
3. [Clinical features and genotype analysis in a case of dyskeratosis congenita].
Yuan SS; Lu YD; Wu CL; Li HP; Ge H; Zhang YM
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Apr; 35(4):553-6. PubMed ID: 25907943
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and genetic features of dyskeratosis congenital with bone marrow failure in eight patients].
Wan Y; An WB; Zhang JY; Zhang JL; Zhang RR; Zhu S; Chang LX; Zhang YC; Liu F; Yang WY; Chen XJ; Zou Y; Chen YM; Zhu XF
Zhonghua Xue Ye Xue Za Zhi; 2016 Mar; 37(3):216-20. PubMed ID: 27033759
[TBL] [Abstract][Full Text] [Related]
5. Sequence analysis of the shelterin telomere protection complex genes in dyskeratosis congenita.
Savage SA; Giri N; Jessop L; Pike K; Plona T; Burdett L; Alter BP
J Med Genet; 2011 Apr; 48(4):285-8. PubMed ID: 21209122
[TBL] [Abstract][Full Text] [Related]
6. TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes.
Walne AJ; Vulliamy T; Beswick R; Kirwan M; Dokal I
Blood; 2008 Nov; 112(9):3594-600. PubMed ID: 18669893
[TBL] [Abstract][Full Text] [Related]
7. TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita.
Savage SA; Giri N; Baerlocher GM; Orr N; Lansdorp PM; Alter BP
Am J Hum Genet; 2008 Feb; 82(2):501-9. PubMed ID: 18252230
[TBL] [Abstract][Full Text] [Related]
8.
Kocheva SA; Gjorgjievska M; Martinova K; Antevska-Trajkova Z; Jovanovska A; Plaseska-Karanfilska D
Balkan J Med Genet; 2021 Nov; 24(2):89-93. PubMed ID: 36249522
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary fibrosis in dyskeratosis congenita: a case report with a PRISMA-compliant systematic review.
Wang P; Xu Z
BMC Pulm Med; 2021 Sep; 21(1):279. PubMed ID: 34479523
[TBL] [Abstract][Full Text] [Related]
10. Exogenous TERC alone can enhance proliferative potential, telomerase activity and telomere length in lymphocytes from dyskeratosis congenita patients.
Kirwan M; Beswick R; Vulliamy T; Nathwani AC; Walne AJ; Casimir C; Dokal I
Br J Haematol; 2009 Mar; 144(5):771-81. PubMed ID: 19036115
[TBL] [Abstract][Full Text] [Related]
11. High resolution melting analysis for the identification of novel mutations in DKC1 and TERT genes in patients with dyskeratosis congenita.
Carrillo J; Martínez P; Solera J; Moratilla C; González A; Manguán-García C; Aymerich M; Canal L; Del Campo M; Dapena JL; Escoda L; García-Sagredo JM; Martín-Sala S; Rives S; Sevilla J; Sastre L; Perona R
Blood Cells Mol Dis; 2012 Oct 15-Dec 15; 49(3-4):140-6. PubMed ID: 22664374
[TBL] [Abstract][Full Text] [Related]
12. Three novel truncating TINF2 mutations causing severe dyskeratosis congenita in early childhood.
Sasa GS; Ribes-Zamora A; Nelson ND; Bertuch AA
Clin Genet; 2012 May; 81(5):470-8. PubMed ID: 21477109
[TBL] [Abstract][Full Text] [Related]
13. Telomere length is associated with disease severity and declines with age in dyskeratosis congenita.
Alter BP; Rosenberg PS; Giri N; Baerlocher GM; Lansdorp PM; Savage SA
Haematologica; 2012 Mar; 97(3):353-9. PubMed ID: 22058220
[TBL] [Abstract][Full Text] [Related]
14. Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: a case report.
Ratnasamy V; Navaneethakrishnan S; Sirisena ND; Grüning NM; Brandau O; Thirunavukarasu K; Dagnall CL; McReynolds LJ; Savage SA; Dissanayake VHW
BMC Med Genet; 2018 May; 19(1):85. PubMed ID: 29801475
[TBL] [Abstract][Full Text] [Related]
15. [Dyskeratosis congenita: an update].
Mialou V; Leblanc T; Peffault de Latour R; Dalle JH; Socié G
Arch Pediatr; 2013 Mar; 20(3):299-306. PubMed ID: 23352883
[TBL] [Abstract][Full Text] [Related]
16. Dyskeratosis congenita.
Dokal I
Hematology Am Soc Hematol Educ Program; 2011; 2011():480-6. PubMed ID: 22160078
[TBL] [Abstract][Full Text] [Related]
17. Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita.
Alter BP; Baerlocher GM; Savage SA; Chanock SJ; Weksler BB; Willner JP; Peters JA; Giri N; Lansdorp PM
Blood; 2007 Sep; 110(5):1439-47. PubMed ID: 17468339
[TBL] [Abstract][Full Text] [Related]
18. A case report of heterozygous TINF2 gene mutation associated with pulmonary fibrosis in a patient with dyskeratosis congenita.
Du H; Guo Y; Ma D; Tang K; Cai D; Luo Y; Xie C
Medicine (Baltimore); 2018 May; 97(19):e0724. PubMed ID: 29742735
[TBL] [Abstract][Full Text] [Related]
19. Novel
Picos-Cárdenas VJ; Beltrán-Ontiveros SA; Cruz-Ramos JA; Contreras-Gutiérrez JA; Arámbula-Meraz E; Angulo-Rojo C; Guadrón-Llanos AM; Leal-León EA; Cedano-Prieto DM; Meza-Espinoza JP
World J Clin Cases; 2022 Nov; 10(33):12440-12446. PubMed ID: 36483815
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
